glp 1 cardiovascular disease Bridging the gap between GLP1-receptor agonists and outcomes: evidence for the role of tirzepatide | Cardiovascular Diabetology Cardiovascular Effects of Glucagon-Like Peptide-1

Just as some foods enhance GLP-1, others may impair optimal GLP-1 signaling: Ultra-processed foods , engineered for rapid absorption, they bypass the slower nutrient-sensing mechanisms that trigger sustained GLP-1 release Refined carbohydrates , white bread, sugary cereals, and processed snacks cause rapid glucose spikes without the fiber, protein, or fat needed to sustain GLP-1 secretion High-saturated-fat meals , saturated fat appears to stimulate less GLP-1 than unsaturated fat, and high-saturated-fat diets are associated with impaired incretin signaling over time Alcohol , regular alcohol consumption is associated with disrupted gut hormone responses, including blunted GLP-1 secretion What is compound GLP-1, and is it safe

Mounjaro (tirzepatide) is approved for managing type 2 diabetes in adults

Robert Kushner: Well, in the first stage, which is that weight gain stage, you're in positive energy balance and the only way you put weight on is you're taking in more calories than you burn off

GLP-1 agonists may be used alone in patients intolerant of metformin or in combination with metformin, thiazolidinediones, and sulfonylureas (or in any combination thereof)